4.0 Article

MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis

Related references

Note: Only part of the references are listed.
Article Hematology

Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study

Nobuhiro Ueno et al.

Summary: This study investigated the influence of concomitant medications on the remission induction of granulocyte and monocyte adsorptive apheresis (GMA) in patients with active ulcerative colitis (UC). The results showed that concomitant medication with 5-aminosalicylic acid and immunosuppressors (IMs) were predictors of clinical remission (CR) after GMA. In patients with a Mayo endoscopic subscore (MES) of 2, concomitant medication with IMs was a significant negative factor for CR after GMA. Additionally, the use of IMs in maintenance therapy with biologics after GMA significantly increased the rate of sustained CR up to 52 weeks compared to biologics alone.

JOURNAL OF CLINICAL APHERESIS (2023)

Article Nutrition & Dietetics

Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis

Yoshikazu Tsuzuki et al.

Summary: The combination of leukocyte depletion by granulocyte and monocyte adsorption apheresis (GMA) and prednisolone (GMA + PSL) appears to be more effective than prednisolone alone in inducing clinical remission and mucosal healing in patients with moderate to severe ulcerative colitis.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2023)

Review Genetics & Heredity

Immunoepigenetic Regulation of Inflammatory Bowel Disease: Current Insights into Novel Epigenetic Modulations of the Systemic Immune Response

Guillermo Bastida et al.

Summary: The immune system and environmental factors play a role in the development of diseases such as inflammatory bowel disease (IBD) by affecting genetics. The pathophysiology of IBD is complex and not fully understood. Epigenetic research provides valuable information for understanding the etiology of IBD.

GENES (2023)

Review Gastroenterology & Hepatology

Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy

Masahiro Iizuka et al.

Summary: This article summarized the use of cytapheresis (CAP) in patients with refractory ulcerative colitis (UC) and discussed its advantages and limitations. The results showed that CAP had similar efficacy in patients with inadequate response to thiopurines or immunomodulators, but limited benefit in patients refractory to biologic therapies. Combination therapy with CAP and biologics could induce clinical remission in over 40% of patients with refractory UC. Extensive prospective studies are needed to understand the efficacy of this combination therapy.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications

Ines Moret-Tatay et al.

Summary: Different plasma miRNA signatures can identify CD patients at high POR risk, optimizing patient outcomes. Nomograms were developed to facilitate the clinical use of these results, aiding in POR risk estimation and patient management. Identified miRNAs participate in apoptosis, autophagy, proinflammatory immunological T-cell clusters, and reactive oxygen species metabolism.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)

Review Biochemistry & Molecular Biology

Roles of microRNAs in inflammatory bowel disease

HyunTaek Jung et al.

Summary: Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people. Recent studies have shown that microRNAs (miRNAs) play an important role in the pathogenesis, diagnosis, and treatment of IBD.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Medicine, General & Internal

Ulcerative colitis

Taku Kobayashi et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Gastroenterology & Hepatology

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review

Ryan Ungaro et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease

Esteban Saez-Gonzalez et al.

DIGESTIVE DISEASES AND SCIENCES (2017)

Article Biochemistry & Molecular Biology

The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling

Rurong Mao et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)

Review Gastroenterology & Hepatology

The emerging role of miRNAs in inflammatory bowel disease: a review

Christopher G. Chapman et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)

Article Pathology

Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome

Nicolaas H. Fourie et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)

Article Multidisciplinary Sciences

Assessing an Improved Protocol for Plasma microRNA Extraction

Ines Moret et al.

PLOS ONE (2013)

Review Pharmacology & Pharmacy

microRNAs and the immune response

Eleni Tsitsiou et al.

CURRENT OPINION IN PHARMACOLOGY (2009)

Article Multidisciplinary Sciences

MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1

Tamia A. Harris et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)